Literature DB >> 21359569

Development and validation of a sensitive, simple, and rapid method for simultaneous quantitation of atorvastatin and its acid and lactone metabolites by liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Joyce S Macwan1, Ileana A Ionita, Miroslav Dostalek, Fatemeh Akhlaghi.   

Abstract

The aim of the proposed work was to develop and validate a simple and sensitive assay for the analysis of atorvastatin (ATV) acid, ortho- and para-hydroxy-ATV, ATV lactone, and ortho- and para-hydroxy-ATV lactone in human plasma using liquid chromatography-tandem mass spectrometry. All six analytes and corresponding deuterium (d5)-labeled internal standards were extracted from 50 μL of human plasma by protein precipitation. The chromatographic separation of analytes was achieved using a Zorbax-SB Phenyl column (2.1 mm × 100 mm, 3.5 μm). The mobile phase consisted of a gradient mixture of 0.1% v/v glacial acetic acid in 10% v/v methanol in water (solvent A) and 40% v/v methanol in acetonitrile (solvent B). All analytes including ortho- and para-hydroxy metabolites were baseline-separated within 7.0 min using a flow rate of 0.35 mL/min. Mass spectrometry detection was carried out in positive electrospray ionization mode, with multiple-reaction monitoring scan. The calibration curves for all analytes were linear (R(2) ≥ 0.9975, n = 3) over the concentration range of 0.05-100 ng/mL and with lower limit of quantitation of 0.05 ng/mL. Mean extraction recoveries ranged between 88.6-111%. Intra- and inter-run mean percent accuracy were between 85-115% and percent imprecision was ≤ 15%. Stability studies revealed that ATV acid and lactone forms were stable in plasma during bench top (6 h on ice-water slurry), at the end of three successive freeze and thaw cycles and at -80 °C for 3 months. The method was successfully applied in a clinical study to determine concentrations of ATV and its metabolites over 12 h post-dose in patients receiving atorvastatin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21359569     DOI: 10.1007/s00216-011-4804-y

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  9 in total

1.  Diabetes mellitus reduces the clearance of atorvastatin lactone: results of a population pharmacokinetic analysis in renal transplant recipients and in vitro studies using human liver microsomes.

Authors:  Miroslav Dostalek; Wai-Johnn Sam; Komal R Paryani; Joyce S Macwan; Reginald Y Gohh; Fatemeh Akhlaghi
Journal:  Clin Pharmacokinet       Date:  2012-09-01       Impact factor: 6.447

2.  Ultra-high performance liquid chromatography tandem mass-spectrometry for simple and simultaneous quantification of cannabinoids.

Authors:  Rohitash Jamwal; Ariel R Topletz; Bharat Ramratnam; Fatemeh Akhlaghi
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2017-02-06       Impact factor: 3.205

3.  HPLC-DAD Method for the Pharmacokinetic Interaction Study of Atorvastatin with Pioglitazone and Cholestyramine in Wistar Rats.

Authors:  Ritesh N Sharma; Shyam S Pancholi
Journal:  Sci Pharm       Date:  2014-03-13

4.  Simultaneous determination of atorvastatin, metformin and glimepiride in human plasma by LC-MS/MS and its application to a human pharmacokinetic study.

Authors:  Srinivasa Rao Polagani; Nageswara Rao Pilli; Ramakrishna Gajula; Venkateswarlu Gandu
Journal:  J Pharm Anal       Date:  2012-10-03

5.  Simultaneous quantitation of atorvastatin and its two active metabolites in human plasma by liquid chromatography/(-) electrospray tandem mass spectrometry.

Authors:  Pankaj Partani; S Manaswita Verma; Sanjay Gurule; Arshad Khuroo; Tausif Monif
Journal:  J Pharm Anal       Date:  2013-09-25

6.  Long-Acting Injectable Statins-Is It Time for a Paradigm Shift?

Authors:  Lee M Tatham; Neill J Liptrott; Steve P Rannard; Andrew Owen
Journal:  Molecules       Date:  2019-07-24       Impact factor: 4.411

7.  Simultaneous Determination of Atorvastatin and Aspirin in Human Plasma by LC-MS/MS: Its Pharmacokinetic Application.

Authors:  Ramakrishna Gajula; Nageswara Rao Pilli; Vasu Babu Ravi; Rambabu Maddela; Jaswanth Kumar Inamadugu; Srinivasa Rao Polagani; Sobha Busa
Journal:  Sci Pharm       Date:  2012-08-06

8.  Development, validation and application of a novel HPLC-MS/MS method for the quantification of atorvastatin, bisoprolol and clopidogrel in a large cardiovascular patient cohort.

Authors:  Richard Myles Turner; Vanessa Fontana; Mark Bayliss; Sarah Whalley; Anahi Santoyo Castelazo; Munir Pirmohamed
Journal:  J Pharm Biomed Anal       Date:  2018-07-03       Impact factor: 3.935

9.  Systemic Lupus Erythematosus Activity Affects the Sinusoidal Uptake Transporter OATP1B1 Evaluated by the Pharmacokinetics of Atorvastatin.

Authors:  Roberta Natália Cestari; Renê Donizeti Ribeiro de Oliveira; Flávio Falcão Lima de Souza; Leandro Francisco Pippa; Glauco Henrique Balthazar Nardotto; Adriana Rocha; Eduardo Antônio Donadi; Vera Lucia Lanchote
Journal:  Clin Transl Sci       Date:  2020-05-28       Impact factor: 4.689

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.